1. Home
  2. APOG vs IVA Comparison

APOG vs IVA Comparison

Compare APOG & IVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Apogee Enterprises Inc.

APOG

Apogee Enterprises Inc.

HOLD

Current Price

$39.02

Market Cap

976.6M

ML Signal

HOLD

Logo Inventiva S.A. American Depository Shares

IVA

Inventiva S.A. American Depository Shares

HOLD

Current Price

$4.43

Market Cap

883.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
APOG
IVA
Founded
1949
2011
Country
United States
France
Employees
N/A
77
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
976.6M
883.8M
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
APOG
IVA
Price
$39.02
$4.43
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
10
Target Price
$47.00
$16.20
AVG Volume (30 Days)
340.6K
1.4M
Earning Date
04-24-2026
03-30-2026
Dividend Yield
3.03%
N/A
EPS Growth
N/A
N/A
EPS
0.54
N/A
Revenue
$1,404,733,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$2.07
$751.20
P/E Ratio
$73.69
N/A
Revenue Growth
3.21
N/A
52 Week Low
$30.75
$2.94
52 Week High
$50.88
$7.98

Technical Indicators

Market Signals
Indicator
APOG
IVA
Relative Strength Index (RSI) 45.34 60.83
Support Level $36.90 $4.45
Resistance Level $39.06 $4.67
Average True Range (ATR) 2.44 0.23
MACD -0.49 0.13
Stochastic Oscillator 1.16 94.07

Price Performance

Historical Comparison
APOG
IVA

About APOG Apogee Enterprises Inc.

Apogee Enterprises Inc is a provider of architectural products and services for enclosing buildings, and high-performance glass and acrylic products used in applications for preservation, protection, and enhanced viewing. The company's operating segment consists of the Architectural Metals Segment, Architectural Services Segment, Architectural Glass Segment, and Performance Surfaces Segment. The company generates the majority of its revenue from the Architectural Metals Segment, which designs, engineers, fabricates, and finishes aluminum window, curtainwall, storefront, and entrance systems used principally in non-residential construction. The company geographically operates in the United States, Canada, and Brazil, with the majority revenue generated from the United States.

About IVA Inventiva S.A. American Depository Shares

Inventiva SA is a France-based clinical-stage biopharmaceutical company focused on the development of oral small-molecule therapies for the treatment of MASH. The wholly-owned research and development facility and a team with expertise and experience in the development of compounds that target nuclear receptors, transcription factors and epigenetic modulation. Leveraging the expertise, the company is also advancing lanifibranor for the treatment of MASH and has a pipeline of earlier-stage therapeutic programs in oncology. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France.

Share on Social Networks: